Literature DB >> 19144707

The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding.

Derek Dube1, Matthew B Brecher, Sue E Delos, Sean C Rose, Edward W Park, Kathryn L Schornberg, Jens H Kuhn, Judith M White.   

Abstract

Entry of ebolavirus (EBOV) into cells is mediated by its glycoprotein (GP(1,2)), a class I fusion protein whose structure was recently determined (J. E. Lee et al., Nature 454:177-182, 2008). Here we confirmed two major predictions of the structural analysis, namely, the residues in GP(1) and GP(2) that remain after GP(1,2) is proteolytically primed by endosomal cathepsins for fusion and residues in GP(1) that are critical for binding to host cells. Mass spectroscopic analysis indicated that primed GP(1,2) contains residues 33 to 190 of GP(1) and all residues of GP(2). The location of the receptor binding site was determined by a two-pronged approach. We identified a small receptor binding region (RBR), residues 90 to 149 of GP(1), by comparing the cell binding abilities of four RBR proteins produced in high yield. We characterized the binding properties of the optimal RBR (containing GP(1) residues 57 to 149) and then conducted a mutational analysis to identify critical binding residues. Substitutions at four lysines (K95, K114, K115, and K140) decreased binding and the ability of RBR proteins to inhibit GP(1,2)-mediated infection. K114, K115, and K140 lie in a small region modeled to be located on the top surface of the chalice following proteolytic priming; K95 lies deeper in the chalice bowl. Combined with those of Lee et al., our findings provide structural insight into how GP(1,2) is primed for fusion and define the core of the EBOV RBR (residues 90 to 149 of GP(1)) as a highly conserved region containing a two-stranded beta-sheet, the two intra-GP(1) disulfide bonds, and four critical Lys residues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19144707      PMCID: PMC2655554          DOI: 10.1128/JVI.01956-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor.

Authors:  Jens H Kuhn; Sheli R Radoshitzky; Alexander C Guth; Kelly L Warfield; Wenhui Li; Martin J Vincent; Jonathan S Towner; Stuart T Nichol; Sina Bavari; Hyeryun Choe; M Javad Aman; Michael Farzan
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

2.  Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity.

Authors:  Anthony Sanchez
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

3.  Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity.

Authors:  Rachel L Kaletsky; Graham Simmons; Paul Bates
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

4.  Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry.

Authors:  Onesmo M Mpanju; Jonathan S Towner; Jason E Dover; Stuart T Nichol; Carolyn A Wilson
Journal:  Virus Res       Date:  2006-07-12       Impact factor: 3.303

5.  Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection.

Authors:  Kartik Chandran; Nancy J Sullivan; Ute Felbor; Sean P Whelan; James M Cunningham
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

6.  Tyro3 family-mediated cell entry of Ebola and Marburg viruses.

Authors:  Masayuki Shimojima; Ayato Takada; Hideki Ebihara; Gabriele Neumann; Kouki Fujioka; Tatsuro Irimura; Steven Jones; Heinz Feldmann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

7.  A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans.

Authors:  Alex S Powlesland; Tanja Fisch; Maureen E Taylor; David F Smith; Bérangère Tissot; Anne Dell; Stefan Pöhlmann; Kurt Drickamer
Journal:  J Biol Chem       Date:  2007-11-05       Impact factor: 5.157

8.  Ebola virus glycoprotein 1: identification of residues important for binding and postbinding events.

Authors:  Melinda A Brindley; Laura Hughes; Autumn Ruiz; Paul B McCray; Anthony Sanchez; David A Sanders; Wendy Maury
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda.

Authors:  Jonathan S Towner; Tara K Sealy; Marina L Khristova; César G Albariño; Sean Conlan; Serena A Reeder; Phenix-Lan Quan; W Ian Lipkin; Robert Downing; Jordan W Tappero; Samuel Okware; Julius Lutwama; Barnabas Bakamutumaho; John Kayiwa; James A Comer; Pierre E Rollin; Thomas G Ksiazek; Stuart T Nichol
Journal:  PLoS Pathog       Date:  2008-11-21       Impact factor: 6.823

10.  Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR.

Authors:  Andrea Marzi; Peggy Möller; Sheri L Hanna; Thomas Harrer; Jutta Eisemann; Alexander Steinkasserer; Stephan Becker; Frédéric Baribaud; Stefan Pöhlmann
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

View more
  96 in total

1.  Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity.

Authors:  Gopi S Mohan; Ling Ye; Wenfang Li; Ana Monteiro; Xiaoqian Lin; Bishu Sapkota; Brian P Pollack; Richard W Compans; Chinglai Yang
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

2.  Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences.

Authors:  John Misasi; Kartik Chandran; Jin-Yi Yang; Bryden Considine; Claire Marie Filone; Marceline Côté; Nancy Sullivan; Giulia Fabozzi; Lisa Hensley; James Cunningham
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

3.  Cell adhesion-dependent membrane trafficking of a binding partner for the ebolavirus glycoprotein is a determinant of viral entry.

Authors:  Derek Dube; Kathryn L Schornberg; Charles J Shoemaker; Sue E Delos; Tzanko S Stantchev; Kathleen A Clouse; Christopher C Broder; Judith M White
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-03       Impact factor: 11.205

4.  Mechanism of human antibody-mediated neutralization of Marburg virus.

Authors:  Andrew I Flyak; Philipp A Ilinykh; Charles D Murin; Tania Garron; Xiaoli Shen; Marnie L Fusco; Takao Hashiguchi; Zachary A Bornholdt; James C Slaughter; Gopal Sapparapu; Curtis Klages; Thomas G Ksiazek; Andrew B Ward; Erica Ollmann Saphire; Alexander Bukreyev; James E Crowe
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

5.  Structural basis for Marburg virus neutralization by a cross-reactive human antibody.

Authors:  Takao Hashiguchi; Marnie L Fusco; Zachary A Bornholdt; Jeffrey E Lee; Andrew I Flyak; Rei Matsuoka; Daisuke Kohda; Yusuke Yanagi; Michal Hammel; James E Crowe; Erica Ollmann Saphire
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

6.  Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.

Authors:  Philipp A Ilinykh; Kai Huang; Rodrigo I Santos; Pavlo Gilchuk; Bronwyn M Gunn; Marcus M Karim; Jenny Liang; Mallorie E Fouch; Edgar Davidson; Diptiben V Parekh; James B Kimble; Colette A Pietzsch; Michelle Meyer; Natalia A Kuzmina; Larry Zeitlin; Erica Ollmann Saphire; Galit Alter; James E Crowe; Alexander Bukreyev
Journal:  Cell Host Microbe       Date:  2020-04-21       Impact factor: 21.023

7.  Alpha5beta1-integrin controls ebolavirus entry by regulating endosomal cathepsins.

Authors:  Kathryn L Schornberg; Charles J Shoemaker; Derek Dube; Michelle Y Abshire; Sue E Delos; Amy H Bouton; Judith M White
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

8.  Structural and molecular basis for Ebola virus neutralization by protective human antibodies.

Authors:  John Misasi; Morgan S A Gilman; Masaru Kanekiyo; Miao Gui; Alberto Cagigi; Sabue Mulangu; Davide Corti; Julie E Ledgerwood; Antonio Lanzavecchia; James Cunningham; Jean Jacques Muyembe-Tamfun; Ulrich Baxa; Barney S Graham; Ye Xiang; Nancy J Sullivan; Jason S McLellan
Journal:  Science       Date:  2016-02-25       Impact factor: 47.728

9.  A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry.

Authors:  Anthony C Wong; Rohini G Sandesara; Nirupama Mulherkar; Sean P Whelan; Kartik Chandran
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

10.  Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity.

Authors:  Chantelle L Hood; Jonathan Abraham; Jeffrey C Boyington; Kwanyee Leung; Peter D Kwong; Gary J Nabel
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.